Stefan Oschmann Appointed New Executive Board Chairman of Merck

Darmstadt, Germany – In its meeting today, the Board of Partners of E. Merck KG appointed Stefan Oschmann (58) as new Chairman of the Executive Board and CEO of Merck KGaA. The appointment will take effect with the end of the Annual General Meeting on April 29, 2016. Stefan Oschmann will succeed Karl-Ludwig Kley (64) [...]

Pistoia Alliance Appoints Steve Arlington As President

Wilmington, DE -- The Pistoia Alliance has appointed Dr Steve Arlington as its new President. Steve joins as the Pistoia Alliance continues to drive to increase the organization’s impact on the global innovation landscape in life sciences R&D. The non-profit Pistoia Alliance is focusing its vision and expanding its work in supporting pre-competitive collaboration in [...]

PowerPlex® Fusion 6C System Receives Approval by the FBI

MADISON, WI USA -- The Promega PowerPlex® Fusion 6C System was granted approval by the FBI for use in laboratories that generate DNA records for the National DNA Index System (NDIS). NDIS, a component of the FBI's CODIS system, is the U.S. national database containing nearly twelve million offender profiles used by authorities to help [...]

Wyss Institute launches new company to provide inexpensive access to super-resolution microscopy

(BOSTON) — The Wyss Institute for Biologically Inspired Engineering at Harvard University today announced the launch of its latest startup company, Ultivue Inc. Ultivue will introduce imaging reagents providing super-resolution capabilities on standard single-molecule microscopes similar to those of expensive specialized instruments. The announcement follows a worldwide licensing agreement between Harvard's Office of Technology Development [...]

InSphero Launches 14 Day Hepatotoxicity Testing Service

Schlieren, Switzerland -- InSphero AG, the leading supplier of easy-to-use solutions for production, culture, and assessment of organotypic 3D cell culture models, has launched a 14 Day Hepatotoxicity Testing Servicedesigned to meet increased demand for contract screening in their patent-pending 3D InSight™ Human Liver Microtissues. The service streamlines toxicity testing of compounds in InSphero’s 3D [...]

Ultivue Announces $5.15 Million Series A Financing

CAMBRIDGE, Mass. -- Ultivue, an early stage life sciences tools company, today announced the completion of $5.15 million in Series A financing from a group of investors including ARCH Venture Partners, Hansjoerg Wyss, and several private investors. Ultivue is based on DNA-PAINT and DNA-Exchange technologies developed at the Wyss Institute for Biologically Inspired Engineering at [...]

Tecan offers walkaway batch processing for the Spark™ 10M reader

Tecan’s innovative Spark 10M multimode reader can now be combined with the company’s Connect™ microplate stacker to offer semi-automated batch processing of up to 50 assay plates. A newly developed software interface allows seamless operation of the Connect stacker through the reader’s SparkControl™ software, helping to streamline laboratory workflows for greater productivity. The Connect is [...]

ENZO Biochem Reaches $10 Million Patent Infringement Settlement with Affymetrix, Inc.

NEW YORK, NY – Enzo Biochem, Inc. (NYSE:ENZ) today announced that it has reached and finalized a settlement with Affymetrix, Inc. (NASDAQ: AFFX) involving payment of $10 million to Enzo in an infringement action brought by Enzo regarding its U.S. Patent No. 7,064,197. Today’s settlement resolving the disputes between Enzo and Affymetrix impacts only one [...]

SeraCare Launches New Quantitative Reference Materials for NGS-Based Tumor Profiling Assays

MILFORD, Mass. -- SeraCare Life Sciences, a leading partner to global in vitro diagnostics manufacturers, announced today that the company's precision medicine business unit has launched its second product in a growing line of reference materials for next-generation sequencing (NGS)-based tumor profiling assays. The SeraseqTM Solid Tumor Mutation Mix-I (AF1-10) contains the same mixture of [...]

UniQuest Licenses Intellectual Property to Organovo for Kidney Toxicity Screening and Drug Development

BRISBANE, Australia and SAN DIEGO -- UniQuest, the main technology transfer and commercialisation company of TheUniversity of Queensland (UQ), has signed an exclusive worldwide licensing agreement with Organovo Holdings, Inc. (NYSE MKT:ONVO), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using its 3D bioprinting technology, to patent applications relating to methodology for [...]

Access IBO on Knowledge Center